Live feed06:00:00·1097dPRReleasevia QuantisnowOvid Therapeutics Announces Collaboration with Graviton Bioscience, Proven Developers of Selective ROCK2 InhibitorsByQuantisnow·Wall Street's wire, on your screen.MGTX· MeiraGTx Holdings plcOVID· Ovid Therapeutics Inc.KDMN· Kadmon Holdings, Inc.Health Care
